The store will not work correctly when cookies are disabled.
N-Methyl-N-[1-(2-pyridyl)pyrazol-3-yl]-1H-indazol-5-amine
ID: ALA3823956
PubChem CID: 127052039
Max Phase: Preclinical
Molecular Formula: C16H14N6
Molecular Weight: 290.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CN(c1ccc2[nH]ncc2c1)c1ccn(-c2ccccn2)n1
Standard InChI: InChI=1S/C16H14N6/c1-21(13-5-6-14-12(10-13)11-18-19-14)16-7-9-22(20-16)15-4-2-3-8-17-15/h2-11H,1H3,(H,18,19)
Standard InChI Key: PNHHRWFIFSETRC-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
-7.2652 0.2078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2729 1.3327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9153 0.7255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0380 -0.7567 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.5020 -1.0835 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6217 1.4865 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6319 2.6865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.0984 -2.4607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2995 -3.7244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.9975 -5.0521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.4963 -5.1114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.2971 -3.8431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.5991 -2.5154 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 1 0
3 6 1 0
6 7 1 0
6 8 1 0
5 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
8 15 2 0
15 19 1 0
18 16 1 0
16 17 2 0
17 8 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 18 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 290.33 | Molecular Weight (Monoisotopic): 290.1280 | AlogP: 2.91 | #Rotatable Bonds: 3 |
Polar Surface Area: 62.63 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.05 | CX Basic pKa: 2.61 | CX LogP: 3.02 | CX LogD: 3.02 |
Aromatic Rings: 4 | Heavy Atoms: 22 | QED Weighted: 0.63 | Np Likeness Score: -2.25 |
References
1. Gardinier KM, Gernert DL, Porter WJ, Reel JK, Ornstein PL, Spinazze P, Stevens FC, Hahn P, Hollinshead SP, Mayhugh D, Schkeryantz J, Khilevich A, De Frutos O, Gleason SD, Kato AS, Luffer-Atlas D, Desai PV, Swanson S, Burris KD, Ding C, Heinz BA, Need AB, Barth VN, Stephenson GA, Diseroad BA, Woods TA, Yu H, Bredt D, Witkin JM.. (2016) Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8., 59 (10): [PMID:27067148] [10.1021/acs.jmedchem.6b00125] |